Trakcel

TrakCel is the market leading designer, developer and deliverer of integrated technologies specifically created in 2012 to manage the international autologous and allogeneic cell, gene and immunotherapy supply chain. Sep 12, 2019 · TrakCel and McKesson would create an end-to-end solution. Combining TrakCel’s data tracking and personalized medicine orchestration software system with McKesson’s high-touch patient platform and expertise will generate an end-to-end solution for the cell and gene therapy industry to better manage the entire therapeutic supply chain. 9 TrakCel reviews.

15.12.2020

The company delivers solutions for clients worldwide and is one of Cardiff's fastest growing technology companies. To view our careers click here. From sample collection through logistics, manufacturing and final treatment, TrakCel's proven technology integrates and orchestrates every aspect of a … When TrakCel started in January 2013, it already had the informal backing of one of the world’s biggest pharmaceutical groups. TrakCel helps companies to monitor and record key events in clinical programmes for pioneering regenerative medicine, which uses a patient’s own cells to help combat life-threatening illnesses like cancer. TrakCel develops bespoke supply chain management software for the cell and gene therapy industry.

TrakCel is a cloud based Cellular Orchestration Platform designed to efficiently safeguard patients and orchestrate processes across regenerative and cell-based therapies. TrakCel’s focus is on ensuring that the right patient gets the right therapy at the right time in a scalable and efficient way.

Orchestrating a modern cell and gene therapy supply chain 1 Sep 2012 http://trakcel.com/ · https://twitter.com/trakcel_ https://www.linkedin.com/company/ trakcel/ · B2B · saas · subscription · health · enterprise software 18 Jul 2017 An interview with Martin Lamb, EVP, TrakCel, conducted by April Cashin-Garbutt, MA (Cantab). What are the main challenges in logistics and 15 Jun 2018 TrakCel.

TrakCel & McKesson partner to help commercialize gene & cell therapy By Nikita Chaurasia Date: 2019-09-13 The combination of these two product suites is designed specifically for the growing number of developers that are nearing the commercial launch of gene and cell therapies.

TrakCel develops bespoke supply chain management software for the cell and gene therapy industry. Our configurable, workflow-driven platform provides our clients with full product tracking to ensure the right patient receives the right treatment every time (Chain of Identity).

Co-founder Fiona Withey is the new Chief Executive Officer of TrakCel, a software developer of orchestration systems for advanced therapies. Co-founder Ravi Nalliah was appointed to the role of Chief Strategy Officer. TrakCel is the market leading designer, developer, and deliverer of integrated technologies specifically created in 2012 to manage the international autologous and allogeneic cell, gene and immunotherapy supply chain. TrakCel's software platform has been developed in collaboration with, and increasingly TrakCel. TrakCel. A critical factor facing the Cell Therapy industry is choosing technologies and partners that can deliver scale. There’s no other field of medicine that requires the level of mass customization of production and careful orchestration of production pathways that cell therapies demand.

From sample collection through logistics, manufacturing and final treatment, TrakCel's proven technology integrates and orchestrates every aspect of a … When TrakCel started in January 2013, it already had the informal backing of one of the world’s biggest pharmaceutical groups. TrakCel helps companies to monitor and record key events in clinical programmes for pioneering regenerative medicine, which uses a patient’s own cells to help combat life-threatening illnesses like cancer. TrakCel develops bespoke supply chain management software for the cell and gene therapy industry. Our configurable, workflow-driven platform provides our clients with full product tracking to ensure the right patient receives the right treatment every time (Chain of Identity).

Medical technology company TrakCel has appointed a new CEO as it looks to its next phase of growth, TrakCel, a leading software developer of orchestration systems for advanced therapies, has announced the appointment of Dr Fiona Withey as chief executive officer and co-founder Ravi Nalliah to the role of chief strategy officer. The TrakCel technology will link, in addition to the manufacturing centre, with Thermo Fisher Scientific’s new Fisher Bioservices CryoHubSM, being built adjacent to the manufacturing centre warehouse. The company's cloud-based platform develops cell therapy process management and supply chain integration technology to meet data management, reporting and analysis needs of clinical trials, enabling clients to avoid the time, cost and risks associated with outdated paper-based systems. TrakCel's proven technology integrates and orchestrates every aspect of Autologous and Allogeneic supply chains in a scalable, compliant and validated technology platform. Lists Featuring This Company City of Cardiff Companies 520 Number of Organizations • $358.4M Total Funding Amount • 155 Number of Investors TrakCel develops bespoke supply chain management software for the cell and gene therapy industry. Our configurable, workflow-driven platform provides our clients with full product tracking to ensure the right patient receives the right treatment every time (Chain of Identity). TrakCel is the market leading designer, developer and deliverer of integrated technologies specifically created in 2012 to manage the international autologous and allogeneic cell, gene and immunotherapy supply chain.

Manufacturing. Related Content 9 TrakCel reviews. A free inside look at company reviews and salaries posted anonymously by employees. 12 Sep 2020 The Cell and Gene Therapy Catapult (CGT Catapult) has signed a partnership agreement with UK-headquartered company TrakCel to 27 Feb 2020 TrakCel was created in 2012 in order to manage the international autologous and allogeneic cell, gene and immunotherapy supply chain. 20 Feb 2020 TrakCel, a leading software developer of orchestration systems for advanced therapies, announced today the appointment of Dr. Fiona Withey 19 Sep 2019 McKesson partners with TrakCel aiming to address the supply chain challenges of cell and gene therapy developers in late stages of TrakCel and Ori Biotech Ltd recently announced a non-exclusive strategic partnership to achieve supply chain orchestration within closed system.

Salaries posted anonymously by TrakCel employees. Co-founder Fiona Withey is the new Chief Executive Officer of TrakCel, a software developer of orchestration systems for advanced therapies. Co-founder Ravi Nalliah was appointed to the role of Chief Strategy Officer. TrakCel is the market leading designer, developer, and deliverer of integrated technologies specifically created in 2012 to manage the international autologous and allogeneic cell, gene and immunotherapy supply chain.

sdf odvetvia zdieľajú cenu
ako čítať graf kryptomeny
dca na mco míle
hviezdne správy xlm 2021
kalkulačka eura na forint

The TrakCel technology will link, in addition to the manufacturing centre, with Thermo Fisher Scientific’s new Fisher Bioservices CryoHubSM, being built adjacent to the manufacturing centre warehouse.

The Company offers orchestrate the cell therapy supply chain for autologous and allogeneic therapies . The TrakCel Solution. Personalized cell and gene therapy software. As more personalized therapies are approved, and markets expand globally, commercial TrakCel is a cloud based Cellular Orchestration Platform designed to efficiently safeguard patients and orchestrate processes across regenerative and TrakCel was founded in 2012 to meet a need in the developing Cell Therapy industry with a principal goal to de-risk complex cell and gene-based therapies www.trakcel.com. 11 Raleigh Walk Brigantine Place Cardiff CF10 4LN United Kingdom +44 (0) 2920 483 729. Activities.